IL6 and COVID-19: In the first phase of the study, participants in the acute phase of COVID-19 presented patterns of elevated inflammation in the form of high concentrations of cytokines such as TNF (TNF–α), LTA (TNF–β), IL–1β, IL–4, IL–6, IL–8, IL–13, and interferon (IFN) –α2.